ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments
The American Journal of Gastroenterology
◽
10.14309/00000434-201710001-00607
◽
2017
◽
Vol 112
◽
pp. S329-S330
◽
Cited By ~ 3
Author(s):
Brian G. Feagan
◽
Séverine Vermeire
◽
William J. Sandborn
◽
Walter Reinisch
◽
Julian Panés
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Active Ulcerative Colitis
◽
Phase 3
Download Full-text
Related Documents
Cited By
References
Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis
Gastroenterology
◽
10.1016/s0016-5085(18)31575-0
◽
2018
◽
Vol 154
(6)
◽
pp. S-380-S-381
Author(s):
Mamoru Watanabe
◽
Satoshi Motoya
◽
Kenji Watanabe
◽
Haruhiko Ogata
◽
Takanori Kanai
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Japanese Patients
◽
Active Ulcerative Colitis
◽
Phase 3
Download Full-text
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-Maintenance
The American Journal of Gastroenterology
◽
10.14309/00000434-201210001-01665
◽
2012
◽
Vol 107
◽
pp. S673-S674
Author(s):
William Sandborn
◽
Brian Feagan
◽
Colleen Marano
◽
Richard Strauss
◽
Jewel Johanns
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Blind Study
◽
Double Blind Study
◽
Active Ulcerative Colitis
◽
Phase 3
◽
Double Blind
◽
Safety And Efficacy
Download Full-text
Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study)
Journal of Gastroenterology
◽
10.1007/s00535-017-1326-1
◽
2017
◽
Vol 52
(10)
◽
pp. 1101-1111
◽
Cited By ~ 20
Author(s):
Toshifumi Hibi
◽
Yuya Imai
◽
Asako Senoo
◽
Kentaro Ohta
◽
Yoshifumi Ukyo
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Japanese Patients
◽
Controlled Study
◽
Active Ulcerative Colitis
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
Download Full-text
Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Intestinal Research
◽
10.5217/ir.2018.16.2.233
◽
2018
◽
Vol 16
(2)
◽
pp. 233
◽
Cited By ~ 11
Author(s):
Satoshi Motoya
◽
Mamoru Watanabe
◽
Hyo Jong Kim
◽
Young Ho Kim
◽
Dong Soo Han
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
East Asian
◽
Active Ulcerative Colitis
◽
Phase 3
◽
Asian Patients
◽
Three Phase
◽
Subgroup Analyses
◽
East Asian Patients
Download Full-text
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
The Lancet Gastroenterology & Hepatology
◽
10.1016/s2468-1253(21)00295-8
◽
2021
◽
Cited By ~ 2
Author(s):
Severine Vermeire
◽
Peter L Lakatos
◽
Timothy Ritter
◽
Stephen Hanauer
◽
Brian Bressler
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Active Ulcerative Colitis
◽
Phase 3
◽
Double Blind
Download Full-text
Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Intestinal Research
◽
10.5217/ir.2018.16.3.499
◽
2018
◽
Vol 16
(3)
◽
pp. 499
◽
Cited By ~ 2
Author(s):
Satoshi Motoya
◽
Mamoru Watanabe
◽
Hyo Jong Kim
◽
Young Ho Kim
◽
Dong Soo Han
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
East Asian
◽
Active Ulcerative Colitis
◽
Phase 3
◽
Asian Patients
◽
Three Phase
◽
Subgroup Analyses
◽
East Asian Patients
Download Full-text
Fr531 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY
Gastroenterology
◽
10.1016/s0016-5085(21)01552-3
◽
2021
◽
Vol 160
(6)
◽
pp. S-350
Author(s):
Laurent Peyrin-Biroulet
◽
Edward V. Loftus
◽
Silvio Danese
◽
Séverine Vermeire
◽
William J. Sandborn
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Active Ulcerative Colitis
◽
Efficacy And Safety
Download Full-text
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
The Lancet Gastroenterology & Hepatology
◽
10.1016/s2468-1253(21)00338-1
◽
2021
◽
Author(s):
David T Rubin
◽
Iris Dotan
◽
Aaron DuVall
◽
Yoram Bouhnik
◽
Graham Radford-Smith
◽
...
Keyword(s):
Ulcerative Colitis
◽
Induction Therapy
◽
Randomised Controlled Trials
◽
Controlled Trials
◽
Active Ulcerative Colitis
◽
Phase 3
◽
Two Phase
◽
Randomised Controlled
Download Full-text
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
The Lancet Gastroenterology & Hepatology
◽
10.1016/s2468-1253(21)00298-3
◽
2021
◽
Author(s):
Laurent Peyrin-Biroulet
◽
Ailsa Hart
◽
Peter Bossuyt
◽
Millie Long
◽
Matthieu Allez
◽
...
Keyword(s):
Ulcerative Colitis
◽
Randomised Controlled Trial
◽
Maintenance Therapy
◽
Tumour Necrosis Factor
◽
Tumour Necrosis
◽
Controlled Trial
◽
Phase 3
◽
Previously Treated
◽
Randomised Controlled
◽
Necrosis Factor
Download Full-text
Vedolizumab Maintenance Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
The American Journal of Gastroenterology
◽
10.14309/00000434-201210001-01522
◽
2012
◽
Vol 107
◽
pp. S609-S610
◽
Cited By ~ 2
Author(s):
Brian Feagan
◽
Paul Rutgeerts
◽
Bruce Sands
◽
William Sandborn
◽
Jean-Frederic Colombel
◽
...
Keyword(s):
Ulcerative Colitis
◽
Maintenance Therapy
◽
Phase 3
◽
Double Blind
◽
Multicenter Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close